Anchorage Capital Group, L.L.C.

Fundamental diversified ★Signal services_media specialist (83%) CIK 1300714
Long book
$436.3M
Q1 2026
Positions
3
Top-10 weight
100%
concentration
Last quarter
+2.1%
SPY +14.8%
Turnover
33%
of book per quarter

Strategy in plain words

auto-generated from filings

Anchorage Capital Group, L.L.C. is a diversified fundamental manager, specialised in services_media (83% of the long book), running a $436.3M US long book across 3 positions.

The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: EQUIPMENTSHARE.COM INC-A, SENTINELONE INC -CLASS A, GINKGO BIOWORKS HOLDINGS INC.

Over the last 9 quarters its long book ran on average 10.4pp per quarter behind the S&P 500, beating the index in 2 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q1 2024
-27.3%
Q2 2024
+5.7%
Q3 2024
-2.6%
Q4 2024
-18.8%
Q1 2025
+11.6%
Q2 2025
+12.3%
Q3 2025
-20.2%
Q4 2025
-16.1%
Q1 2026
+2.1%

Sector allocation

Services media
83%
Technology
15%
Healthcare
2%

Long book by quarter

$377.6M
Q1 2024
$316.8M
Q2 2024
$374.9M
Q3 2024
$272.5M
Q4 2024
$239.9M
Q1 2025
$258.7M
Q2 2025
$117.4M
Q3 2025
$88.6M
Q4 2025
$436.3M
Q1 2026

What does Anchorage Capital own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
EQPT EQUIPMENTSHARE.COM INC-AServices media17.8M$362.0M83.0%New
S SENTINELONE INC -CLASS ATechnology4.9M$63.6M14.6%Held
DNA GINKGO BIOWORKS HOLDINGS INCHealthcare1.7M$10.7M2.5%Held

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRMay 15, 20263$436.3M canonicalSEC ↗
Q4 202513F-HRFeb 17, 20262$88.6M canonicalSEC ↗
Q3 202513F-HRNov 14, 20254$117.4M canonicalSEC ↗
Q2 202513F-HRAug 14, 20256$258.7M canonicalSEC ↗
Q1 202513F-HRMay 15, 20257$250.1M canonicalSEC ↗
Q4 202413F-HRFeb 14, 20257$284.2M canonicalSEC ↗
Q3 202413F-HRNov 14, 20247$382.0M canonicalSEC ↗
Q2 202413F-HRAug 14, 20248$324.0M canonicalSEC ↗
Q1 202413F-HRMay 15, 20249$384.3M canonicalSEC ↗